Abstract
Purpose
To grade myopic choroidal neovascularization (CNV) patients according to the new myopic maculopathy classification (A: atrophy, T: traction, N: neovascularization-ATN) and analyze the correlation in between atrophy, traction and neovascularization.
Methods
Fifty-one eyes of 41 patients with the diagnosis of pathologic myopia and myopic CNV were included in this clinical practice study. Patients were graded according to the recently described ATN classification. Color fundus photographs were used to grade the atrophy and spectral domain optical coherence tomography scans were used to grade traction and neovascularization. Active myopic CNVs were treated with intravitreal anti-vascular endothelial growth factor (VEGF) injections. Chi-square test was used to test the categorical variants and univariate logistic regression analysis was used to predict the independent risk factors of myopic CNV scar formation.
Results
Active myopic CNV was observed most frequently in the group with patchy chorioretinal atrophy. Grade of the atrophy and female gender were significantly associated with myopic CNV scar in the univariate logistic regression tests. Multivariate logistic regression showed that atrophy grading is the independent predictor of myopic CNV scar.
Conclusion
ATN classification is a practical and comprehensive system to grade myopic CNV. Atrophy is an independent predictor for myopic CNV scar and patchy chorioretinal atrophy requires a more careful examination and close follow-up for the risk of CNV development.
Similar content being viewed by others
Availability of data and materials
Raw data will be presented upon request.
Code availability
Not applicable.
References
Resnikoff S, Pascolini D, Mariotti SP, Pokharel GP (2008) Global magnitude of visual impairment caused by uncorrected refractive errors in 2004. Bull World Health Organ 86:63–70
Matsumura S, Kuo AN, Saw SM (2019) An Update of Eye Shape and Myopia. Eye Contact Lens 45:279–285
Holden BA, Jong M, Davis S, Wilson D, Fricke T, Resnikoff S (2015) Nearly 1 billion myopes at risk of myopia-related sight-threatening conditions by 2050 - time to act now. Clin Exp Optom 98:491–493
Holden BA, Fricke TR, Wilson DA, Jong M, Naidoo KS, Sankaridurg P et al (2016) Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 2050. Ophthalmology 123:1036–1042
Ohno-Matsui K (2017) What is the fundamental nature of pathologic myopia? Retina 37:1043–1048
Shimada N, Tanaka Y, Tokoro T, Ohno-Matsui K (2013) Natural course of myopic traction maculopathy and factors associated with progression or resolution. Am J Ophthalmol 156:948–957
Tokoro T (1988) On the definition of pathologic myopia in group studies. Acta Ophthalmol Suppl 185:107–108
Wang NK, Wu YM, Wang JP, Liu L, Yeung L, Chen YP et al (2016) Clinical characteristics of posterior staphylomas in myopic eyes with axial length shorter than 26.5 millimeters. Am J Ophthalmol 162:180–190
Liu HH, Xu L, Wang YX, Wang S, You QS, Jonas JB (2010) Prevalence and progression of myopic retinopathy in Chinese adults: the Bei**g Eye Study. Ophthalmology 117:1763–1768
Wong TY, Ferreira A, Hughes R, Carter G, Mitchell P (2014) Epidemiology and disease burden of pathologic myopia and myopic choroidal neovascularization: an evidence-based systematic review. Am J Ophthalmol 157:9–25
Curtin BJ, Karlin DB (1971) Axial length measurements and fundus changes of the myopic eye. Am J Ophthalmol 71:42–53
Avila MP, Weiter JJ, Jalkh AE, Trempe CL, Pruett RC, Schepens CL (1984) Natural history of choroidal neovascularization in degenerative myopia. Ophthalmology 91:1573–1581
Ohno-Matsui K, Kawasaki R, Jonas JB, Cheung CM, Saw SM, Verhoeven VJ et al (2015) International photographic classification and grading system for myopic maculopathy. Am J Ophthalmol 159:877–883
Ruiz-Medrano J, Montero JA, Flores-Moreno I, Arias L, García-Layana A, Ruiz-Moreno JM (2019) Myopic maculopathy: Current status and proposal for a new classification and grading system (ATN). Prog Retin Eye Res 69:80–115
Neelam K, Cheung CM, Ohno-Matsui K, Lai TY, Wong TY (2012) Choroidal neovascularization in pathological myopia. Prog Retin Eye Res 31(5):495–525
Hera R, Chiquet C, Romanet JP (2013) Surgical removal of subfoveal choroidal neovascularization in pathologic myopia: a 12-year follow-up study. Int Ophthalmol 33(6):671–676
Neo HY, Neelam K, Yip CC, Quah HM, Au Eong KG (2013) Choroidal neovascularization following laser in situ keratomileusis for high myopia: a case series. Int Ophthalmol 33(1):27–34
Iwase A, Araie M, Tomidokoro A, Yamamoto T, Shimizu H, Kitazawa Y et al (2006) Prevalence and causes of low vision and blindness in a Japanese adult population: the Tajimi Study. Ophthalmology 113:1354–1362
Hsu WM, Cheng CY, Liu JH, Tsai SY, Chou P (2004) Prevalence and causes of visual impairment in an elderly Chinese population in Taiwan: the Shihpai Eye Study. Ophthalmology 111:62–69
Hopf S, Korb C, Nickels S, Schulz A, Münzel T, Wild PS et al (2020) Prevalence of myopic maculopathy in the German population: results from the Gutenberg health study. Br J Ophthalmol 104(9):1254–1259
Zou M, Wang S, Chen A, Liu Z, Young CA, Zhang Y et al (2020) Prevalence of myopic macular degeneration worldwide: a systematic review and meta-analysis. Br J Ophthalmol 104(12):1748–1754
Cohen SY, Laroche A, Leguen Y, Soubrane G, Coscas GJ (1996) Etiology of choroidal neovascularization in young patients. Ophthalmology 103:1241–1244
Ruiz-Medrano J, Flores-Moreno I, Ohno-Matsui K, Cheung CMG, Silva R, Ruiz-Moreno JM (2020) Validation of the recently developed ATN classification and grading system for myopic maculopathy. Retina 40(11):2113–2118
Chen Q, He J, Hu G, Xu X, Lv H, Yin Y et al (2019) Morphological characteristics and risk factors of myopic maculopathy in an older high myopia population-based on the new classification system (ATN). Am J Ophthalmol 208:356–366
Ikuno Y, Jo Y, Hamasaki T, Tano Y (2010) Ocular risk factors for choroidal neovascularization in pathologic myopia. Invest Ophthalmol Vis Sci 51:3721–3725
Cheung CM, Loh BK, Li X, Mathur R, Wong E, Lee SY et al (2013) Choroidal thickness and risk characteristics of eyes with myopic choroidal neovascularization. Acta Ophthalmol 91:580–581
Wong TY, Ohno-Matsui K, Leveziel N, Holz FG, Lai TY, Yu HG, Lanzetta P, Chen Y, Tufail A (2015) Myopic choroidal neovascularisation: current concepts and update on clinical management. Br J Ophthalmol 99(3):289–296
Acknowledgements
None.
Funding
No funding was received to assist with the preparation of this manuscript.
Author information
Authors and Affiliations
Contributions
All authors contributed to the study conception, design, material preparation, data collection and analysis. The first draft of the manuscript was written by Rengin Aslıhan Kurt and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflicts of interest
The authors have no conflicts of interest to declare.
Consent to participate
Not applicable.
Consent for publication
Not applicable.
Ethics approval
Subjects have given their written informed consent and the study protocol was approved by the ethics committee of Başkent University.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Kurt, R.A., Sarıgül Sezenöz, A., Akkoyun, I. et al. The correlation of atrophy, traction and neovascularization in myopic choroidal neovascularization according to a novel myopic maculopathy classification system (atrophy (A), traction (T), neovascularization (N): ATN). Int Ophthalmol 42, 2925–2932 (2022). https://doi.org/10.1007/s10792-022-02423-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10792-022-02423-1